Inhibition of Glucose Transporter 1 Overexpression in Mesangial Cells by Rhein

J Zhu,Z Liu,Y Li
DOI: https://doi.org/10.3760/j.issn:0578-1426.2001.08.011
2001-01-01
Abstract:OBJECTIVE:To evaluate the effect of rhein on the overexpression of glucose transporter 1(GLUT 1) in mesangial cells transfected with GLUT 1 gene in vitro.METHODS:Rat mesangial cells were transduced with the human GLUT 1 gene(MCGT 1) by retrovirus vector. Mesangial cells transduced with bacterial beta-galactosidase(MCLacZ) were used as control. Glucose uptake was detected by 2-deoxyglucose(2-DG). Cell volume, RNA/DNA ratio and protein/DNA ratio were evaluated by flow cytometry analysis. The synthesis of collagen IV and fibronectin were measured by 3H-proline incorporation and flow cytometry. The activity of glutamine: fructose-6-phosphate aminotransferase (GFAT) was assayed by spectrophotometry method. The expression of collagen IV, fibronectin and GFAT were analyzed by RT-PCR.RESULTS:MCGT 1 exhibited a higher 2-DG uptake with increased Vmax value as compared to MCLaZ(741 +/- 60.5) dpm.microgram prot-1 vs (92.2 +/- 9) dpm.microgram prot-1, (P < 0.01), Even cultured in normal glucose concentration, MCGT1 showed cell hypertrophy, including increased cell volume, RNA/DNA and protein/DNA ratios; increased synthesis of extracellular matrix. 3H-proline incorporation significantly enhanced in MCGT1 compared with that in the control(7.0 +/- 0.4) dpm.cell-1 vs (4.6 +/- 0.6) dpm.cell-1, (P < 0.01); and GFAT activity increased to 1.8 fold. Rhein could inhibit 2-DG uptake of MCGT1(560 +/- 64) dpm.microgram prot-1 vs (741 +/- 60.5) dpm.microgram prot-1, (P < 0.05) in a dose-dependent manner, and reverse the cell hypertrophy of MCGT 1. In addition, rhein could diminish the enhanced GFAT activity of MCGT 1 with no influence in mRNA expression.CONCLUSION:It is suggested that glucose transport activity was an important modulator of cellular glucose metabolism in mesangial cells. Rhein could ameliorate the metabolic derangement of MCGT 1 by decreasing glucose uptake. These findings have led us closer to the identification of therapeutic approaches to abort GLUT 1 overexpression in diabetic nephropathy.
What problem does this paper attempt to address?